Surge in Demand of Skin Grafts for Burn Treatments is projected to drive the Demand for Deep Partial-Thickness Thermal Burns Treatment Market

In 2018, as per the World Health Organization (WHO), an estimated count of 180,000 deaths occurred every year due to chronic burn injuries. Due to these rising burn cases worldwide, there is an emergent need for better and advanced treatment options. The most commonly considered treatment, skin graft usage, is also increased due to the growth in the demand for burn care treatments. First-degree or superficial burns can heal using the body's natural healing mechanism. Still, second, third-degree, or full-thickness burns require skin grafting surgeries to fast healing with minimum scar formations. Due to increasing demand, various skin grafts are in use, including allograft, xenograft, autograft, meshed skin grafts, and sheet grafts. Hence, the enormous advantages of the latest skin grafting procedures providing minimal scar application have further enhanced the growth of the global deep partial-thickness thermal burns treatment market.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-deep-partial-thickness-thermal-burns-treatment-market

Data Bridge Market Research analyses that the deep partial-thickness thermal burns treatment market is expected to grow at a CAGR of 8.1% in the forecast period of 2021 to 2028 and is expected to reach USD 2,072.86 million by 2028. Biologics dressing serves as a significant option for many acute burn injuries. Biologic burn wound healing facilitates the re-establishment of innate repair mechanisms. They are mostly incorporated with active biological agents like anti-oxidant, antimicrobial or anti-inflammatory attributes. Therefore, due to these affirmative advantages, our market's rising advancements in biologics to treat wounds are a major driver.

Surge in Healthcare Expenditure globally is expected to drive the market's growth rate

People are getting more aware of their health and also there is alertness for preventive healthcare. Emphasis on healthcare is gaining popularity. The advanced technology available in the healthcare system is helping manufacturers to produce novel anti-herpetic drugs, which are used to treat various conditions of deep partial-thickness thermal burns treatment and lead to higher survival rates. A developed health infrastructure guarantees a strong and healthy manpower for providing healthcare services. It includes advanced machines and developed pharmaceutical industry. For instance, According to Centers for Medicare and Medicaid Services, in 2018, National Health Expenditures  (NHE) rises by 4.6% to USD 3.60 trillion (USD 11,172 per person), which accounts for 17.7% of GDP. National health spending will reach to USD 6.20 trillion by 2028 with an average annual rate of 5.4% for 2019-2028. Improving and increasing healthcare infrastructure and expenditure will increase the process of installation of advanced technologies for the manufacturing of anti-herpetic drugs and APIs, which will enhance the product profile in the leading market, for this reason, increasing healthcare expenditure and infrastructure across the world is acting as an opportunity for boosting the demand of the global deep partial-thickness thermal burns treatment market. 

Report Scope and Market Segmentation

Segment Analysis:

The global deep partial-thickness thermal burns treatment market is categorized into five notable segments that are burn type, treatment, route of administration, end user, and distribution channel. 

• On the basis of burn type, the global deep partial-thickness thermal burns treatment market is segmented into fire burn injuries, scald burn, and hot objects. In 2021, the fire burn injuries segment is expected to dominate the market growing with the highest CAGR of 6.8% in the forecast period of 2021 to 2028 as the incidence rate of fire burn has increased in recent years globally.
• On the basis of treatment, the global deep partial-thickness thermal burns treatment market is segmented into initial wound care, physical and occupational therapy, and others. In 2021, the initial wound care segment is expected to dominate the market growing with the highest CAGR of 9.0% in the forecast period of 2021 to 2028 as it is required in every type of burn and has fewer side effects and infections.
• On the basis of route of administration, the global deep partial-thickness thermal burns treatment market is segmented into topical, oral, and others. In 2021, the topical segment is expected to dominate the market growing with the highest CAGR of 11.8 %

The topical segment is expected to dominate the market growing with the highest CAGR of 11.8 %

In 2021, the topical segment is expected to dominate the market growing with the highest CAGR of 11.8 % in the forecast period of 2021 to 2028 as topical applications work faster and have lesser side effects.

• On the basis of end user, the global deep partial-thickness thermal burns treatment market is segmented into hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others. In 2021, the hospital segment is expected to dominate the market growing with the highest CAGR of 10.0% in the forecast period of 2021 to 2028 due to the growing demand for deep partial-thickness thermal burns treatment.
• On the basis of distribution channel, the global deep partial-thickness thermal burns treatment market is segmented into direct tender, hospital pharmacy, online pharmacy, retail pharmacy, and others. In 2021, the direct tender segment is expected to dominate the market growing with the highest CAGR of 10.0% in the forecast period of 2021 to 2028due to the presence of a variety of products available there.

Major Players

Data Bridge Market Research recognizes the following companies as the major deep partial-thickness thermal burns treatment market players in deep partial-thickness thermal burns treatment market are Smith+Nephew (U.K.), Mölnlycke Health Care AB (Sweden), Convatec Inc. (U.K.), 3M (U.S.), Coloplast Group (Denmark), Medtronic (Ireland), Accell Group, (Netherlands), Anika Therapeutics, Inc., (U.S), B. Braun Melsungen AG, (Germany), Cardinal Health., (U.S), DeRoyal Industries, (U.S), Hollister, (U.S), Integra LifeSciences Corporation, (U.S), Medline Industries, Inc., (U.S), PAUL HARTMANN AG, (Germany), and Essity Aktiebolag (Sweden).

Market Development

• In January 2020, Temple Health's Center Director, Dr. Lisa Rae, states that they provide their advanced spray-on skin cell technology called RECALL systems to treat severe burns. In this procedure, they take the victim's skin cell-like keratinocytes, fibroblasts, and melanocytes. And immerse them in an enzyme solution to make a suspension liquid. This suspension is sprayed over the entire burn for treatment. This procedure is now distributed across the world
• In June 2021, Mallinckrodt plc announced that the U.S. Food and Drug Administration or FDA had approved StrataGraft (which is allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns and containing the intact dermal elements and surgical intervention which is clinically indicated
• In September 2020, Vericel Corporation announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of their submitted Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns. NexoBrid is used for eschar removal (debridement) in adults with deep partial-thickness and full-thickness thermal burns
• In August 2020, RenovaCare announced that the US Food and Drug Administration (FDA) conditionally approved the application to start a clinical trial to increase the safety and efficiency of autologous stem cells rendered by its CellMist™ System from donor skin which is to be applied topically with the SkinGun™ spray device for the treatment of burn wounds

Regional Analysis

Geographically, the countries covered in the deep partial-thickness thermal burns treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

Asia-Pacific is the dominant region in deep partial-thickness thermal burns treatment market during the forecast period

Asia-Pacific dominated the deep partial-thickness thermal burns treatment market owing to the increase in investments in healthcare sector within the region. Asia-Pacific will continue to dominate the deep partial-thickness thermal burns treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to the increasing healthcare expenditure.

North America is estimated to be the fastest-growing region in deep partial-thickness thermal burns treatment market

North America is expected to grow during the forecast period due to this region's rising research and developmental activities. In addition, the growing presence of major market players and rising disposable income are expected to propel the market's growth rate in this region.

For more detailed information about the deep partial-thickness thermal burns treatment market report, click here – https://www.databridgemarketresearch.com/reports/global-deep-partial-thickness-thermal-burns-treatment-market